Form D · Biotechnology
Tetragenetics Inc
Arlington, MA · CIK 0001409403
Offering snapshot reported Sep 29, 2020 · SEC filing
- Reported sold
- $1.01M Offering amount: $2M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Sep 19, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2020 | Initial | $1,012,497 | No comparison | 13 | SEC filing |
| Jul 19, 2018 | Initial | $809,770 | No comparison | 15 | SEC filing |
| Mar 1, 2017 | Initial | $1,097,072 | No comparison | 21 | SEC filing |
| Nov 24, 2015 | Initial | $336,000 | No comparison | 8 | SEC filing |
| Mar 9, 2015 | Initial | $338,191 | No comparison | 8 | SEC filing |
| Jun 5, 2013 | Initial | $502,000 | No comparison | 24 | SEC filing |
| Aug 28, 2012 | Initial | $2,474,231 | No comparison | 55 | SEC filing |
| Dec 7, 2009 | Initial | $490,308 | No comparison | 9 | SEC filing |
| Aug 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-376594
Source: Form D, filed Sep 29, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ellen Baron | Director |
| Marco Cacciuttolo | Director, Executive |
| Theodore Clark | Director, Executive |
| Marc Franzman | Executive |
| Robert Gailus | Director |
| William E Gordon | Director, Executive |
| Martin Gorovsky | Director |
| Daniel Grau | Director |
| R Douglas Kahn | Director, Executive |
| R. Douglas Kahn | Director, Executive |
| Peter Kiener | Director |
| Ben Machielse | Director |
| Kevin O'brien | Executive |
| John Reilly | Executive |
| Christopher Taron | Director |
| Alison Taunton Rigby | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
91 Mystic Street
Arlington, MA, 02474
Arlington, MA, 02474